ESC 0/1小时与High-STEACS 0/2-0/3小时hs-cTn算法快速诊断NSTEMI的前瞻性多中心比较
该前瞻性国际多中心诊断研究纳入4663例急性胸痛患者,平行应用ESC 0/1小时与High-STEACS 0/2-0/3小时算法,以hs-cTnI-Architect时ESC 0/1小时算法敏感性更高(100% vs 98.1%,P<0.001),但排除组比例更低(52% vs 72.5%,P<0.001),特异性则ESC 0/1小时算法一致更高,外部验证队列(n=2485)结果一致。
要点
- ESC 0/1小时算法敏感性更高但排除效率更低,High-STEACS 0/2-0/3小时算法排除比例更高。
- ESC 0/1小时算法在全部hs-cTnT/I检测中特异性一致高于High-STEACS 0/2-0/3小时算法。
- 两者总体性能相当且优异,医院可依临床与运营优先级选择hs-cTn路径。
核心结论
- 两种算法总体性能相当且优异,使用hs-cTnI时ESC 0/1小时算法敏感性更高,而High-STEACS 0/2-0/3小时算法排除效率更高。
- ESC 0/1小时算法对NSTEMI的特异性在所有hs-cTnT/I检测中一致更高。
- 研究结果为医院选择与自身临床和运营优先级匹配的hs-cTn路径提供了直接且经外部验证的证据。
研究设计与样本
- 前瞻性、国际、多中心诊断研究,纳入因急性胸部不适就诊于急诊科的患者,最终诊断由2名独立心内科医生集中裁定。
- 共纳入4663例合格患者(中位年龄61岁,女性32%),其中663例(14.2%)为1型NSTEMI。
- 两种算法平行应用,使用3种hs-cTn检测:hs-cTnI-Architect、hs-cTnI-Centaur/Atellica和hs-cTnT-Elecsys。
- 结果在独立前瞻性诊断研究外部验证队列(n=2485;中位年龄64岁;女性37%)中确认。
主要发现
- 使用hs-cTnI-Architect时,ESC 0/1小时算法敏感性为100%(95%CI:99.4-100),高于High-STEACS 0/2小时路径的98.1%(95%CI:96.7-99),P<0.001。
- 使用hs-cTnI-Architect时,ESC 0/1小时算法排除组比例为52%,低于High-STEACS 0/2小时路径的72.5%,P<0.001。
- hs-cTnI-Centaur/Atellica的差异相似但较小,hs-cTnT-Elecsys则无差异。
- ESC 0/1小时算法对NSTEMI的特异性在所有hs-cTnT/I检测中一致高于High-STEACS 0/2-0/3小时路径。
- 使用High-STEACS 0/3小时路径及外部验证队列时,上述结果得到确认。
关键数值与推荐
- 主要诊断终点为1型NSTEMI。
- ESC 0/1小时算法使用hs-cTnI-Architect时敏感性100%(95%CI:99.4-100),排除组比例52%。
- High-STEACS 0/2小时路径使用hs-cTnI-Architect时敏感性98.1%(95%CI:96.7-99),排除组比例72.5%。
- ESC 0/1小时算法特异性在所有hs-cTnT/I检测中一致高于High-STEACS 0/2-0/3小时路径。
临床怎么用
- 医院可依据临床与运营优先级选择hs-cTn路径:重视敏感性可选ESC 0/1小时算法,重视排除效率可选High-STEACS 0/2-0/3小时算法。
- 使用hs-cTnI检测时,ESC 0/1小时算法敏感性更高但排除比例更低,需权衡漏诊风险与急诊分流效率。
- 使用hs-cTnT检测时两种算法差异不明显,选择时可更多考虑流程与资源因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal approach for the early diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) remains uncertain, because no large trials have been performed. Accordingly, guideline recommendations differ and do not overall give a clear answer. OBJECTIVES: The authors aimed to directly compare the European Society of Cardiology 0/1-hour algorithm (ESC 0/1h-algorithm) and the high-sensitivity troponin in the evaluation of patients with acute coronary syndrome 0/2-hour or 0/3-hour pathway (High-STEACS 0/2h-0/3h-pathway) in patients presenting with acute chest discomfort. METHODS: This prospective, international, multicenter, diagnostic study enrolled patients presenting to the emergency department with acute chest discomfort. Final diagnoses were centrally adjudicated by 2 independent cardiologists. The primary diagnostic endpoint was NSTEMI type 1. Both algorithms were applied in parallel using 3 high-sensitivity cardiac troponin (hs-cTn) assays: hs-cTnI-Architect, hs-cTnI-Centaur/Atellica, and hs-cTnT-Elecsys. The findings were externally validated in an independent prospective diagnostic study. RESULTS: Among 4,663 eligible patients (median age: 61 years; 32% women), 663 (14.2%) had NSTEMI type 1. The ESC 0/1h-algorithm had higher sensitivity when using hs-cTnI-Architect (100% [95% CI: 99.4-100]) compared with the High-STEACS 0/2h-pathway (98.1% [95% CI: 96.7-99], P < 0.001), but the proportion of patients assigned to the rule-out group was lower (52% vs 72.5%, P < 0.001). Differences were similar but were less pronounced for hs-cTnI-Centaur/Atellica and absent for hs-cTnT-Elecsys. Specificity was consistently higher for the ESC 0/1h-algorithms vs the High-STEACS 0/2h-0/3h-pathways for all hs-cTnT/I-assays. These findings were confirmed when using High-STEACS 0/3h-pathways and in the external validation cohort (n = 2,485; median age: 64 years; 37% women). CONCLUSIONS: Overall, both algorithms exhibited comparable and excellent performance. When using hs-cTnI, the ESC-0/1h-algorithms showed higher sensitivity, whereas the High-STEACS 0/2h-0/3h-pathways demonstrated higher efficacy. Consistently, the ESC 0/1h-algorithms showed higher specificity for NSTEMI. These findings provide direct, validated evidence to guide hospitals in selecting an hs-cTn pathway aligned with their clinical and operational priorities. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study [APACE], NCT00470587; Biomarkers in Acute Cardiac Care [BACC], NCT02355457).
引用
- Glaeser J, Lopez-Ayala P, Kellner C, et al. Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study. J Am Coll Cardiol. 2026. PMID: 41706062. doi:10.1016/j.jacc.2025.12.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。